TP53 and neoplasm: Furthermore, a study on breast cancer in mice, where TQ was administered orally at a dose of 65 mg/kg body weight, revealed that TQ reduced tumor markers, suppressed histopathological changes, and regulated the expression of Brca1, Brca2, P53, and Id-1 mutation [90].